OpenURL Connection Search

Select item for more details and to access through your institution.

Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models.
Published in:
Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29517-9
By:
- Lissa, Delphine;
- Takahashi, Nobuyuki;
- Desai, Parth;
- Manukyan, Irena;
- Schultz, Christopher W.;
- Rajapakse, Vinodh;
- Velez, Moises J.;
- Mulford, Deborah;
- Roper, Nitin;
- Nichols, Samantha;
- Vilimas, Rasa;
- Sciuto, Linda;
- Chen, Yuanbin;
- Guha, Udayan;
- Rajan, Arun;
- Atkinson, Devon;
- El Meskini, Rajaa;
- Weaver Ohler, Zoe;
- Thomas, Anish
Publication type:
Article
A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid Tumors.
Published in:
Oncologist, 2023, v. 28, n. 5, p. 460, doi. 10.1093/oncolo/oyad023
By:
- LaRose, Meredith;
- Connolly, Roisin M;
- O'Sullivan, Ciara C;
- Velcheti, Vamsidhar;
- Vilimas, Rasa;
- Gano, Katherine;
- Bates, Susan E;
- Pommier, Yves;
- Thomas, Anish
Publication type:
Article
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair–targeted therapies.
Published in:
Science Translational Medicine, 2021, v. 13, n. 578, p. 1, doi. 10.1126/scitranslmed.abc7488
By:
- Tlemsani, Camille;
- Takahashi, Nobuyuki;
- Pongor, Lorinc;
- Rajapakse, Vinodh N.;
- Tyagi, Manoj;
- Wen, Xinyu;
- Fasaye, Grace-Ann;
- Schmidt, Keith T.;
- Desai, Parth;
- Kim, Chul;
- Rajan, Arun;
- Swift, Shannon;
- Sciuto, Linda;
- Vilimas, Rasa;
- Webb, Santhana;
- Nichols, Samantha;
- Figg, William Douglas;
- Pommier, Yves;
- Calzone, Kathleen;
- Steinberg, Seth M.
Publication type:
Article

Found: 3

Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models.

A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid Tumors.

Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair–targeted therapies.